Search for:
Avacta Group plc
About
pre
|CISION
TM
Affimer
®
Pipeline
News
Investors
Careers
Contact
About
About Avacta
Group Team
Scientific Resources
Intellectual Property
pre
|CISION
TM
pre
|CISION
TM
pre
|CISION PDC
pre
|CISION+
pre
|CISION ADC
Partners
Clinical trials
Team
Affimer
®
Pipeline
News
Investors
Investors
CEO Welcome
Key info
Corporate Governance
Resources
Share price
RNS News
Research
Careers
Job vacancies
Benefits of working at Avacta
Contact
About
About Avacta
Group Team
Scientific Resources
Intellectual Property
pre
|CISION
TM
pre
|CISION
TM
pre
|CISION PDC
pre
|CISION+
pre
|CISION ADC
Partners
Clinical trials
Team
Affimer
®
Pipeline
News
Investors
Investors
CEO Welcome
Key info
Corporate Governance
Resources
Share price
RNS News
Research
Careers
Job vacancies
Benefits of working at Avacta
Contact
Home
News
filter by:
view all
|
Blogs
|
Diagnostics
|
Investors
|
Therapeutics
News
08 Nov 2022
Result of the Open Offer
Investors
31 Oct 2022
Avacta to Present at Virtual Theranostics FAP Summit
Investors
|
Therapeutics
28 Oct 2022
Block Listing Six Monthly Return
Investors
20 Oct 2022
Director/PDMR Shareholding
Investors
20 Oct 2022
Admission of the Company’s Ordinary Shares
Investors
20 Oct 2022
Posting of the Company’s Open Offer Circular
Investors
18 Oct 2022
Result of placing
Investors
18 Oct 2022
Proposed placing, open offer and issue of convertible bonds
Diagnostics
|
Investors
18 Oct 2022
Proposed acquisition of Launch Diagnostics
Diagnostics
|
Investors
29 Sep 2022
Interim Results for the Period Ended 30 June 2022
Investors
Posts navigation
Older posts
Newer posts
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok